1Amery A, Birkenhager WH, Bulpitt Cj, et al. The European Working Party on high blood pressure in Elderly. Am J Med, 1991,90(Suppl 3A):ls-70s.
2SHEP Cooperative Research Group. Prevention of stroke by antihyper-tensive drug treatnent in older persons with isolated hyper ten-sion. Final result of the Systolic hypertension in the Elderly Program(SHEP).JAMA,1991,265:3255-3264.
3Dahlof B, Lindholm LH, Hanssorn L, et al. Morbidity and mortality in the Swedish Trial in old patients with Hypertension (STOP-Hypertension. Lance, 1991,338:1281-1285.
4MRC working party. Medical Research Council trial of treatment of hypertension in older adults: principle results. BMJ, 1992,304:405-412.
5Majoy outcomes in high-risk hypertensive patients randomized to angioten-sin-converting enzyme inhibitor or calcium channel blocker vs diuetic. The antihypertensive and lipid-lowering treatment to prevent heart attack (ALLHAT). JAMA, 2002,288:2981-2997.
1Degli EE, Berto P, Ruffo P, et al. The PANDORA project: result of the cost of illness analysi. J Hum Hypertents. 2001. 15:329-334.
2Degli EE, Sturani A, Degli EL, et al. Pharmacoutilization of antihypertensive drugs: a model of analysis. Int J Clin Pharmacol Ther ,2001,39:251-258.
3Johannesson M, Dahlof B, Lintholm LH, et al. The cost-effectiveness of treating hypertension in elderly people-an analysis of the Swedish TrialOld Patients with Hypertension (STOP Hypertension). J Intern Med ,1993,234 : 317-323.
4Cost effectiveness of combination therapy. Based on a presentation by Daniel Hilleman, Pharm D. Am J Manag Care , 1999, 5( Suppl 7):S449-454.
5Dunn EC, Small RE. Economic of antihypertensive therapy in the elderly. Drugs Anging ,2001, 18: 515-525.
6Pearce KA, Furberg CD, Psaty BM, et al. Cost-mininization and the number need to treat in uncomplicated hypertension. Am J Hypertens,1998, 11:618-629.
7Ramsey SD, Neil N, Sullivan SD, et al. An economic evaluation of the JNC hypertension guidelines using data from randomized controlled trial. Am Board Fam Prac, 1999, 12: 105-114.
8Elliott WJ, Weir DR, Black HR. Cost-effectiveness of the lower treatment goal (of JNC VI) for diabetic hypertensive patients. Arch Intern Med, 2000, 160: 1277-1283.
9Siegal D, Lopez J. Trends in antihypertensive drug use in the United States : do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure.JAMA, 1997,278 : 1745-1748.
10The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic : The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ( ALLHAT).JAMA, 2002, 288:2981-2997.
